摘要 |
<p>Described are compounds of Formula (I) which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-IR), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c- FMS, c-KIT, or PDGFR kinases.</p> |
申请人 |
DECIPHERA PHARMACEUTICALS, LLC;CALDWELL, TIMOTHY MALCOLM;SAMARAKOON, THIWANKA;VOGETI, LAKSHMINARAYANA;PATT, WILLIAM C.;AHN, YUMI |
发明人 |
CALDWELL, TIMOTHY MALCOLM;SAMARAKOON, THIWANKA;VOGETI, LAKSHMINARAYANA;PATT, WILLIAM C.;AHN, YUMI;FLYNN, DANIEL L.;KAUFMAN, MICHAEL D. |